<法規>
<法規性質>命令</法規性質>
<英文法規名稱>Regulations for Publication of Drug Information</英文法規名稱>
<中文法規名稱>藥物資料公開辦法</中文法規名稱>
<法規網址>https://law.moj.gov.tw/Eng/LawClass/LawAll.aspx?pcode=L0030061</法規網址>
<最新英文異動日期>20120731</最新英文異動日期>
<廢止註記>
</廢止註記>
<附件 />
<沿革內容><![CDATA[1. Promulgated by the Executive Yuan, the Department of Health Order Wei-Shu-Yao No. 950301000, on February 27, 2006; The Regulations shall be effective on the day of the publication.
2. Amended by the Executive Yuan, the Department of Health Order Shu-Shou-Shi No. 1011405253, on July 31, 2012.]]></沿革內容>
<前言><![CDATA[]]></前言>
<法規內容>
  <條文>
    <條號>Article 1</條號>
    <條文內容><![CDATA[These regulations are enacted pursuant to the Paragraph 2 of Article 40-1 of the Pharmaceutical Affairs Act.]]></條文內容>
  </條文>
  <條文>
    <條號>Article 2</條號>
    <條文內容><![CDATA[The central competent health authority may, if necessary, publicize summary of assessment reports of drug approvals, and the data below which are submitted by pharmaceutical firms in their application for registration, holding and keeping by the authority. The health authority shall keep confidential for any trade secrets in the new drug applications:
1. ingredient and instruction of the drug.
2. summary of clinical trial protocols.
3. information of drug risk management plan and drug safety.]]></條文內容>
  </條文>
  <條文>
    <條號>Article 3</條號>
    <條文內容><![CDATA[The central competent health authority shall publicize the registration data of medicinal product by following methods:
1. Publish on government bulletin or other publications.
2. Transmit through telecommunications networks or by other ways to provide the public for online search.
3. Any other possible ways of which the information can be made available to the public.]]></條文內容>
  </條文>
  <條文>
    <條號>Article 4</條號>
    <條文內容><![CDATA[These Regulations shall come into force on the date of promulgation.]]></條文內容>
  </條文>
</法規內容>
</法規>
